As I warned you, my analysis showed that Versarien (VRS) was going to run out of cash by Christmas. And so today, after shameless ramping this website exposed HERE, HERE and HERE, a bailout placing is announced, though raising just £1.85 million gross, call it £1.7 million net, at just 10p. Where does one start?

AIM-listed jam-tomorrow (if ever) IoT investment Company Tern plc (TERN) has followed up yesterday’s ramparoonie over Wyld (listed on the joke Nasdaq-of-the-north exchange in Stockholm) with a big announcement of a new contract for jewel-in-the-crown Device Authority worth $1.2 million…….over five years.

My five slam-dunk sells for 2022, Tern plc (TERN), Barkby (BARK), Trafalgar Property (TRAF) and URU Metals (URU) of the AIM Casino, and sub-Standard-Listed AIQ (AIQ), were heading nicely towards a clean sweep, with four winners out of five at the end of September. As Tern heads for a desperate cash crisis within weeks, how are the scores-on-the-doors this month?

AIM-listed online ladies fashionwear purveyor Sosandar (SOS) served up a half-year (to September) trading update this morning. The highlights were appealing: revenues up 72% year-on-year and a profit before tax of £0.1 million made good reading. But as Tom Winnifrith oft opines, sales is vanity and profit is a matter of opinion: what really matters is cash.

I think we have firmly established that AIM-listed jam-tomorrow investment company Tern plc (TERN) needs yet another placing some time before Q2 2023 despite its recent fundraising efforts. But that is just to keep the lights on. What about its portfolio of cash-hungry mutts? When will the next call on Tern’s (lack of) cash be? Wyld, with its warrant call mid-December? Or might there be a call for funding from another of Tern’s portfolio first?

I am still nursing an ouzo-inflicted headache following Wednesday’s bailout placing at just 7.5p by AIM-listed Tern plc (TERN). Tom Winnifrith has covered this here and here already, but there are still more reasons to sell.

AIM-listed Haydale (HAYD), fresh from its bailout keep-the-lights-on placing and open offer at 2p in which it raised £5.5 million (gross) last month, has announced its full year results, to June 30, this morning. The numbers are truly grim.

Death spirals have been a hot topic of conversation here on ShareProphets, the issue being whether they decimate share prices and are thus a major Red Flag.  Tom pointed out here that there is no causal link but with Cloudbreak Discovery (CDL) of the sub-Standard List, there seems to be another issue.

It is now just three months to the end of the year and at the last count my slam-dunk sells were one up and four down. Not too bad, but will I get a clean sweep?

AIM-listed Advanced Oncotherapy released its interim results to June 2022 this morning – deadline day (never a good sign). The numbers are horrific – and so it seems are the prospects!

AIM bad-boy, suspended for the past five months for failing to release accounts, Catenae Innovation (CTEA) has at last released full year accounts to September 2021 and Interim results to March 2022. Oh, and it has announced a death spiral package from Sanderson Capital, under which the lender seems to do very well indeed (at shareholders’ expense).

The end of August is generally regarded as the end of summer here in the UK, but the official date for the beginning of autumn is actually September 23 for this year. It is a moot point for most, but not so for AIM-listed Advanced Oncotherapy (AVO) – which had been promising that its first LIGHT medical proton bean unit would be up and running by the end of the summer.

AIM-listed Jam tomorrow investment company Tern plc (TERN) released awful interim results to June 30 2022 today – there is no jam tomorrow! With negative net current assets and a loss of £2.4 million, a failed takeover and a cash-crisis, it couldn’t get much worse…….but it does!

Another Neil Woodford disruptive pipe-dream is set to bite the dust next month. Having been bailed out repeatedly by Woodford as he sank his investors’ cash into a black hole, now that Woodford has gone there doesn’t seem to be anyone interested in taking on AIM-listed Eve Sleep (EVE) and this morning investors were warned of what we have been saying was inevitable for years.

Previously writing on finnCap Group (FCAP), in April with the shares down to 26.5p I noted the outlook looked set to be even further of ‘more complex markets’ for it and to avoid from a still more than £47 million market cap. What now after a further trading update, with the shares currently down to 16.5p?

AIM-listed POS Inspirit Energy (INSP) has updated the market on its waste heat recovery system, telling of great things from trials in Poland and plenty of jam tomorrow. It reads so beautifully: shareholders must be thrilled at being updated. So what’s the catch?

Pure Gold, of the TSX-V (PGM) and the LSE (PUR), updated the market with news that it has achieved record Gold production in August and reaffirmed Q3 guidance, driven (we are told) by record ore throughput and improved grades. The shares are up on the news by 12.6% to 7.6p (still a country mile below the 10.25p at which I said, last April, that it was certainly not one for me – and I am supposed to be a Gold bull!) but there is a massive fly in the ointment.

AIM-listed graphene outfit Haydale (HAYD) triumphantly announced the completion of its latest bailout keep-the-lights-on fundraising this morning. With £5 million in the bag – and an open offer to existing shareholders to raise a bit more at 2p – the company was pleased to announce that this latest fundraise, worth around half of the current market capitalisation, would be used predominantly to fund the general working capital needs of the business. Tosh! It will be used to fund the seemingly unending ongoing losses! What is it about AIM-listed graphene businesses?

Former Neil Woodford favourite, fully listed Esken (ESKN), has offered up a trading statement this morning ahead of its interim results to today – which won’t appear until November. The statement offers some glimmer of hope, which saw the shares rise initially by as much as 7% before turning tail as the market read into the detail.

At the not-quite-end-of-July update my five slam-dunk sells had registered three wins, one loss and a draw. As the bear market rally cracks in the wake of Jerome Powell’s muscle-flexing at Jackson’s Hole, how are AIM-listed Tern (TERN), Barkby (BARK), URU Metals (URU), Trafalgar Property (TRAF) and Standard-Listed AIQ (AIQ) doing now?

Sub-Standard-Listed Cloudbreak Discovery (CDL) shares have had an eventful existence since IPO in June last year. Listed at 3p, the stock collapsed down to around 1.4p within six months before an unusual series of boardroom trades ramped the shares up as high as 13.25p in March – when the company got a smash’n’grab placing away at 7.5p. Now they are down at just 1.425p: what on earth is going on?

We had news this morning that CPI inflation went through 10% in the UK – bad news, as this surely means further increases to interest rates over here. That won’t help businesses such as online clothing retailer, AIM-listed ASOS (ASC) and I sense that the company’s difficulties don’t end there, for this morning the CFO/COO Mr Mat Dunn is to leave at the end of October. But the statement is, I fear, highly disingenuous.

Sub-Standard-Listed Cloudbreak Discovery (CDL) has announced an interesting looking deal to fund Iron Forge Holdings (III) Ltd (IF3) with a $1.5 million loan on seemingly advantageous terms. Interesting looking until one considers where the $1.5 million is coming from!

I was puzzled by the re-announcement of the valuation by AIM-listed Tern (TERN) with regard to its holding in FundamentalVR (FVRVS). After all, this was due to a second issue of B-series shares on the same terms as the first. Surely, then, we knew all that already, and it would not have changed. Silly me - this is Tern, after all!

AIM-listed jam-tomorrow IoT investment company Tern (TERN) announced yesterday afternoon that investee Fundamental VR (FVRVS limited) had raised a further £5 million in a second tranche of the Series B fundraise first announced back in May. That seems positive, so why the immediate share price drop in the market?

Having watched (sub)-Standard listed Cloudbreak Discovery (CDL) get a smash-and-grab placing away at 7.5p per share (a 20% discount to the prevailing price) back in March on the back of some “interesting” boardroom buying, I confidently predicted that the stock would slump back to the IPO price of 3p before too long. Well, it has done worse than that, now sitting not so far away from the all-time low, at 1.775p. And today comes news of a stack of options and warrants in a midday RNS entitled “Amendment to the Stateline Option Agreement”. Except that as far as I can make out, the meat was the issue of the best part of 10 million options and warrants to directors, PMDRs, other members of staff and consultants. Oh, and don’t forget the death spiral!

Albeit a week late, it is time for another update on my five slam-dunk sells for 2022. Last time four out of the five had slipped into the red – is there any further improvement this time?

Sub-Standard listed AIQ (AIQ) – the dog listed by champagne quoffing Andrew Monk and VSA Capital which spent most of its first six months on the market suspended and then blew most of its cash on a disastrous RTO in a fit of reverse alchemy – announced interim results to April 2022. Could the story get any worse? Er…..

I commented before that the proposed takeover of AIM-listed Pires Investments (PIRI) by AIM-listed jam-tomorrow investment company Tern (TERN) reminded me of Tom Winnifrith’s image of two drunks trying to prop each other up, as neither had any money. Today we learnt that they had fallen over each other and were lying in a heap on Paternoster Square.

AIM-listed member of the Woodford disruptive revolutionary front, Eve Sleep (EVE), has updated the market this morning on its formal sale process and trading. The news is not good and I suggest that anyone holding shares here is truly certifiable.

AIM-listed Yu Group (YU.) released its half-year trading update for the six months to June 2022 yesterday morning. As ever, it made a good impression but does it mean good results are on the way, or will there be a hidden nasty?

When AIM-listed Haydale (HAYD) released a trading update AHEAD of its full year at the end of June, seemingly indicating that all was well, I wondered if that was really the case. Well, this morning we know the answer to that, after a full-year trading update. All most certainly is not well – and the shares are already down by 5.5%.

My ongoing bearishness towards AIM-listed Pure Gold (PUR) continues to bear fruit. I first wrote about the company in April when the shares were 10.25p, having been technically insolvent as at FY21. The shares were ramped up and then came the inevitable dump as the company had a reset with new management. So all was set fair? Er……yesterday we got a strategic review. Uh-Oh.

Having reached the halfway point of the year, it is time to look once again at my five slam dunk sells for the year. At the end of May the scores were 3 down and two up. Has there been any improvement? The not-so fabulous five were Tern plc (TERN), URU Metals (URU), Barkby Group (BARK) and Trafalgar Property (TRAF) of the AIM Casino and AIQ (AIQ) of the sub-Standard list.

In an extraordinary announcement this morning, AIM-listed Vela Technologies (VELA) has announced that it has just discovered that – unbeknown to its Board – it had apparently invested £300,000 into Aquis-listed TruSpine (TSP) as part of a subscription announced by TruSpine on 31 May 2022. What???!! And then this afternoon a clarification.

I cannot help but notice that sub-Standard-Listed Cloudbreak Discovery (CDL) is back below its IPO price of 3p, at 2.8p in the middle. Call me Mystic Meg – for having sailed up as high as 13.25p on a ridiculous ramp, I commented in April that the shares have since drifted down to just 4.6p and seem set to drop back below the IPO price in due course. Where’s my Ouzo?

I commented only last week that whilst the receipt of $748,400 on a loan from Argentina was a welcome development, I wasn’t sure it was enough to keep the wolf from the door at AIM-listed Rurelec (RUR) – the carcass left behind after it was run into the ground by Peter Earl. Today, at 2.38pm, the company slipped out its results for calendar 2021. So how’s the cash position?

As we reach the end of month five – we are almost half way – here is the latest from my small-dunk sells for this year. The biggest feature of the portfolio is that all the companies need to rattle the tin and whilst that has been less of a problem during the everything bubble, market conditions are deteriorating fast. So I expect a few accidents in the coming months.

My continued advice to keep well away from fully-listed Esken (ESKN) – the former Stobart Group (STOB) seems to have been well placed. Quite apart from the serial Red-Flags-At-Night announcements, there is the small matter of the share price continuing to collapse. A year ago the shares were 32.9p and I said sell; last August they had fallen to 15p and I said keep well away. Now they are just 8.77p and there are a few Red Flags in the FY22 results (to February) to suggest that there is still further to fall.

First thing this morning AIM-listed Trafalgar Property (TRAF) announced a board appointment, and the shares shot out of the traps like rocket on speed, trebling in the first two hours of trading. The excitement was to do with the arrival of Dr Paul Francis Challinor as an executive director. Dr Challinor specialises in indoor hydroponic vertical farming – so the tomatoes-in-test-tubes have returned!

We have reached the end of month 4 – how are my five slam-dunk sells of AIM-listed Barkby Group (BARK), Tern plc (TERN), Trafalgar Property (TRAF), URU Metals (URU and Standard-listed AIQ (AIQ)  doing?

Carclo (CAR) “is pleased to report that the business expects to report a strong performance for the year” and that “demand in the group's key markets remains strong coming into the new financial year”. So what of a current share price of 24.5p, down nearly 10%?!...

AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) today provided an update in the form of its AGM statement. As ever, it is full of hyperbole but offers few hard numbers. The ShareProphets RNS Translation Service explains all…..

As we await the latest heavily discounted bucket shop bailout placing – or worse – from AIM-listed UK Oil & Gas (UKOG), we have already had ramptastic 2D seismic processing from its duff Turkish assets and this morning it was announced that CEO Lyin’ Steve Sanderson has been buying shares. Quick, follow the man……..or not!

On 12^th April 2022 AIM-listed Advanced Oncotherapy (AVO) announced an equity fundraise of £1.735 million at 25p a pop – a premium to market, but only at par price. We were told that the fundraise has been conducted through a direct subscription with the Company (the "Subscription") for a total of 6,940,000 new ordinary shares. So the money was in the bank, right? Wrong….

Having posted my thoughts on sub-Standard-listed Pure Gold (PUR) - dual listed in Toronto (TSXV: PGM) - over the bank holiday weekend, today we had an update from the company. And it was not good - my conclusion at the weekend was that it was more a case of Fool’s Gold than Pure Gold and this morning I was totally vindicated. Is it time for an Ouzo already?

I cannot help but notice that a good many of the shares of which I am a bear are dropping at the moment. With some, it is a case of the ramptastic froth being blown away. With others, it is surely a case of gravity asserting itself.

AIM-listed Haydale (HAYD) issued an RNS Reach this morning to announce that it is celebrating a double award win, with the Group picking up an award at the prestigious 2022 British Engineering Excellence Awards ('BEEAs') and named as a winner of the Kidney Research UK MedTech Competition respectively. But…..

I commented on the Interims to December from AIM-listed Barkby Group (BARK) yesterday, noting a massive black hole in net current assets to the tune of a whopping £12.4 million. So how is the company paying for this acquisition – and the comprehensive refurbishment by June 2022?

AIM-listed Barkby Group (BARK) reported its interims to December 2021 yesterday morning. Having picked up on this outfit over Christmas, when it reported diabolical FY results to 1 July 2021 on Christmas Eve – an automatic Red Flag – was there any improvement this time?

OK, we got it wrong over AIM-listed Tern (TERN) and the cost of converting its first round of warrants in Wyld with regard to needing an urgent placing. But the maths still suggests an imminent placing is needed to keep the lights on so whilst we have goofed on the specifics the general point was correct.

It seems my slam-dunk sells for 2022 – AIM-listed Tern plc (TERN), Catenae Innovation (CTEA), Trafalgar Property (TRAF) and URU Metals (URU) along with sub-Standard listed AIQ (AIQ) is set for a very interesting few days ahead which could see disaster strike for at least two of these companies.

AIM-listed jam tomorrow IoT investment company Tern plc (TERN) badly needs to get a fundraise away as the closing date for cashing in its first round of warrants at Wyld, listed on the Nasdaq First North joke market in Stockholm approaches. I reckon it has got at best a couple of weeks and probably only one week before disaster strikes. The only question for me is whether the disaster will be the collapse of Wyld or just a massively discounted bucket shop placing-induced collapse in Tern’s share price.

AIM-listed Advanced Oncotherapy (AVO) finally announced the fundraise that was obviously coming yesterday – at 25p, the nominal price (and the lowest price allowed by law). But the funding round is inadequate and the company will have to return to rattle the tin once again in a couple of months’ time.

I noted at the beginning of this month that AIM-listed Advanced Oncotherapy (AVO) needs to get a fundraise away pronto, but that its shares were threatening to drop below the nominal price of 25p, below which it cannot issue new shares by law. On Friday the shares closed at 24p (mid) and I would suggest that Advanced – or, rather, its shareholders – have a big problem.

It was announced yesterday that CEO Lyin’ Steve Sanderson of AIM-listed UK Oil and Gas (UKOG) has again been buying shares in the market. But if you think this might be a buying signal, you need your head examining.

Tom Winnifrith pointed to yesterday morning’s RNS Reach from AIM-listed jam-tomorrow IoT investment company Tern plc (TERN), noting that in effect the investment made was worth around a grand. So even if it was a rampant success it would never make a jot of difference. But not satisfied with that Tern issued another RNS Reach intra-day detailing an internet of things standards project with reference to its biggest investee Device Authority. So was this any more significant?

Previously writing on promotional products group 4imprint (FOUR), in November with the shares down to around 3000p I questioned further encouraging progress. So what of now full-year results?…

Shares in Aim-listed URU Metals (URU) have been on the rise and this morning the company issued an RNS regarding drilling news from 74.8% majority-owned ZEB Nickel, listed in Toronto (ZBNI) regarding the Zebediela Nickel project in South Africa. The RNS is, natch, very positive but I wonder if it really is.

For most of the last year, AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) has survived because its supporters were truly sold on Tern’s portfolio being worth a multiple of the official NAV per share which allowed Tern to issue more and more shares like there is no tomorrow at a huge premium to NAV per share, even if at massive discounts to the prevailing share price. Until now.

AIM-listed and surely sort of cash Advanced Oncotherapy (AVO) announced yesterday morning that Prof Stephen Myers, executive director and the chairman of ADAM – Advanced’s development team in Geneva – had bought a total of 140,000 shares. At 27.64p (on average) that is £38,700 worth of stock. It sounds quite impressive, but this is certainly not a situation where it is advisable to follow director buying. In fact, I take the opposite view: the shares are a sell.

AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) announced yesterday that it is to participate in the Sure Valley Ventures UK Software Technology Fund, to the tune of an initial £90,000 and a total of £5 million over the next ten years. So where is the money coming from as the deadline for converting Tern’s first round of warrants in Wyld (due at the end of the month) ticks down to an inevitable discounted bucket-shop placing?

AIM-listed Mediazest (MDZ) announced its full year results to September this morning and the numbers were a horror show. The shares are 18% down as I write, to 0.0775p and there is every reason to expect them to fall further.

AIM-listed Advanced Oncotherapy (AVO) has announced that its first proton beam therapy unit at Daresbury has once again been delayed. First it was due in 2021, then the end of 2021, then Q1 2022….now we are told more tests during Q2 and then finalisation of the integration of the remaining high energy accelerating modules and reaching the 230MeV target over the summer. That sounds like Q3 for Mr Godot to finally make an appearance. Or not.

After yesterday’s FY results were released by sub-Standard listed AIQ (AIQ) I pointed out that the recent insiders convertible loan was, we were told yesterday, at a ludicrous interest rate of 5% per day. The usual form for auditing accounts is that the auditors audit not only the numbers in the financial statements, but the notes as well. Yet later that day, the company had to ‘fess up that it had got it all wrong. Talk about being unable to organise a piss-up in a brewery!

I noted yesterday that FY results from sub-Standard-Listed AIQ (AIQ) were due today. To leave one’s results to deadline day is of itself at Red Flag, but a brief nose through the numbers what a horrific shambles has been made of this VSA Capital/ Andrew Monk IPO from 2018. Fortunately, ShareProphets readers were warned right from the off.

AIM-listed graphene play Haydale (HAYD) announced its interim results to December 2021 this morning and despite the advertised £3.84 million of cash, yet another placing is surely inevitable. Revenues fell from £1.28 million to £1.19 million, pre-tax losses increased from £1.93 million to £2.46 million year on year – what’s not to like? But the real problem is the balance sheet.

Just two weeks ago shares in sub-Standard-Listed Cloudbreak Discovery (CDL) were marooned at just 1.75p a pop – a hefty loss on the IPO price of 3p last June . Then they started rising and rising. A few days later it was announced that CEO Kyler Hardy had bought a stack of shares at 3p and sold some at 1.7p. Needless to say, there is no possibility of insider dealing……but now the shares have motored on up to 12p. What’s going on?

I see that shares in AIM-listed Advanced Oncotherapy (AVO) are down to just 26.5p – only a penny and a half above the nominal price. Normally that might not be an issue, but Advanced is a serial non-deliverer of promises and has had to place at regular intervals until now. So what chance a bucket-shop placing to keep the lights on whilst we await the ever-delayed first LIGHT system to even offer a sprinkling of hope for some revenue?

Last week saw yet another RNS Reach announcement from AIM-listed Graphene play Haydale (HAYD). Reach announcements are used for non-regulatory news, ie non-financially significant announcements and advertising, so a deluge of them is a Red Flag for me, indicating it is bucket-shop placing ahoy.

How do you keep an AIM-listed Tern plc (TERN) shareholder in suspense? Why, of course, issue a Portfolio Update with no numbers attached! And that is what we had yesterday morning, from a company desperate to get a big bucket-shop funding round away as it faces a hefty bill to stand its corner at Wyld, which has a round of warrants due to expire at the start of April and not enough cash to pay for full conversion. But perhaps the biggest Red Flag of all was the excuses offered with regard to principal investee Device Authority.

We are just over a month into the year: how are my Slam-Dunk Sells for 2022 doing? My portfolio of disaster for this year was Tern plc (TERN), Trafalgar Property (TRAF), URU Metals (URU) and Barkby Group (BARK) of the world’s most successful growth market and, from the sub-Standard List, AIQ (AIQ).

A rise in the shares of AIM-listed Applied Graphene (AGM) caught my eye today. Like Haydale (HAYD) and Versarien (VRS) – apparently – it is a graphene play on the world’s most successful growth market. So how is the growth here? Er…..

AIM-listed jam-tomorrow investment company Tern plc (TERN) announced yesterday that investee Talking Medicines had raised £1.59 million from a fundraise – including £400,000 from Tern. The company trumpeted that the value of its investment had therefore headed north from £0.86 million to £1.79 million. Is it time for the TERNers to crack open the Ouzo?

As predicted on this fine website, AIM-listed Purplebricks Group (PURP)’s interims to October 2021 are suitably disastrous. But since the company isn’t bust (yet) the market has reacted with relief and the shares are marginally up on the day, at 20.3p – though a long way shy of the 50-60p they were at only last autumn, and a country mile off the £5 at peak Neil Woodford-ramp back in 2017. The opening preamble tries to polish the turd, but a peek at the formal accounts shows that it lost £20.2 million in just six months. During a housing boom where anything standing sold within hours and average prices roofed it as mortgages were almost free to a good home. Yikes – just how bad might it have been in a slump?!

Origo Partners (OPP) was a member of the ShareProphets AIM-China Filthy Forty and is one of the last handful still standing. It was an investment company and lost almost all of the shareholders’ funds as the nest of snakes that was running it made, ahem, questionable investments which either collapsed or just disappeared. In 2017 current Chairman, Mr John Chapman, arrived and the previous board – and Nomad, Smith & Williamson – were given the boot as the past was revealed in all its horrific glory, alongside a series of major write-downs or just write-offs as Mr Chapman applied some common sense to the stated NAV, and in some cases just bothered to find out what the company had bought (if anything at all). But last week came some good news….

I asked on Friday whether AIM-listed jam-tomorrow internet of things investment company Tern plc (TERN) had run into some problems with its proposed listing on the US OTCQB market. A trip to the SEC website asks more questions than it answers.

AIM-listed graphene play Haydale (HAYD) is up to its old tricks again with the release of an RNS Reach telling us that iCraft is using Haydale’s graphene product in a graphene-coated fabric. Yesterday we were told of the appointment of a new Nomad/Broker, today we get an RNS Reach. When’s the placing fellas?

I completely agree that Barclays (BARC) is not an exciting company and I consequently have probably written about it too many times on this website. Anyhow the good news is that this is likely to be the last time I will write about it. It is time for me to sell my Barclays shares.

AIM-listed Graphene play Haydale (HAYD) has appointed FinnCap as Nomad and Broker. So is it fundraising ahoy?

2021 was not a good year for bears. Markets were in a rip-roaring bull phase and in my view all common sense went out of the window, so even the most ridiculous speculative plays went up. But my strong view is that 2022 will be different: QE is being tapered away, interest rates are rising, inflation is soaring and government helicopter money is no longer there (at least for now). In 2021, bears had to hide behind the sofa and short positions could be attacked by an army of pitch-fork armed private investors. That is not the case now and I expect some hefty declines as a result.

Entirely predictably, AIM-listed John Zorbas vehicle URU Metals (URU) has slipped out its interim results on deadline day (never a good sign) in no-one-is-watching week, the few trading days between Christmas and New Year. As such it is a fabulous day to bury bad news……and there is, of course, plenty of bad news.

AIM-listed Mediazest (MDZ) offered up a trading statement yesterday and I wonder why. There were positive noises, of course, but this was a trading statement apparently covering the second half of the year ending 30 September 2021! Last year it offered up its year-end statement, including the second lockdown, on November 12^th 2020. Why has it taken Mediazest an extra month in an environment somewhat less affected by Covid this year?

AIM-listed jam-tomorrow internet of things investment company Tern plc (TERN) has announced a fundraise at investee INVMA resulting is an upwards revaluation of its investment. Two other investors have stepped up to the plate in the form of Foresight and Mercia, stumping up £1.925 million between them (presumably of other people’s money) to add to a further investment from Tern of just £0.2 million. Good news for INVMA, as it now has cash – and good news for Tern as at least one hungry mouth to feed has been satiated for the time being.

I have been watching Companies House with interest recently, regarding AIM-listed jam-tomorrow internet of things investment company Tern plc (TERN) and its principal investee Device Authority (DA). Following news of the bailout investment of yet more cash into DA, I have a few questions. Call be a pedant, but……

Aquis-listed Rutherford Health (RUTH) – formerly Proton Partners – announced this morning that it has secured bridge financing from shareholders including Neil Woodford’s former stamping ground of Schroder UK Public Private Trust (SUPP) – formerly Woodford Patient Capital – and LF Equity Income Fund – the unsaleable rump left over from the Woodford Equity Income fund – to raise up to £10 million in the form of various loans costing 15% per annum. The old saying that if you owe the bank a quid you’ve got a problem, but if you owe the bank a million quid then it is the bank which has the problem is writ large here.

AIM-listed graphene products company Haydale (HAYD) has released its full year results to June 30 2021. Amongst the highlights we are told of a “robust trading performance” and the “Summary of Results” shows that cash outflow from operations was down by 52% whilst cash at year end was up by 100% at £1.64 million. So all is well, right? Think again…..

Well surprise, surprise! AIM-listed Advanced Oncotherapy (AVO) has announced that the first fully operational LIGHT system has been delayed from the end of this year to the end of Q1 next year. I noted HERE that the delay announced this morning was pretty well baked in. Given that we have moved from “could slip into Q1 2022” to “around the end of Q1 2022” in the space of less than two and a half months, it seems to me that further slippage is highly likely. Indeed, despite this morning’s announcement, one wonders whether any progress has been made at all since the announcement of diabolical interims at the end of September. So there will be at least another quarter sans revenue……what about the cash?

Having posted my five slam-dunk sells for 2021 at the start of the year and watched in amazement as the market bid up complete rubbish, it is time to take stock as the year draws to a close. My sells were Tern (TERN), Catenae Innovation (CTEA), URU Metals (URU) and Yu Group (YU.) – all roll-overs from 2020 – and Trafalgar Property (TRAF), which came in as a replacement for the defunct ShareProphets AIM-China Filthy Forty play Walcom (WALG).

AIM-listed jam-tomorrow IoT Investment company Tern (TERN) has announced yet another roll-over with regard to the loan notes from principal investee Device Authority. This is a repeating pattern: every six months the maturity is pushed back another six months and the latest is that they have been pushed back to the end of March 2022. One might gently wonder if Device Authority will ever be able to pay them off or whether the conversion terms will be invoked due to lack of cash.

Aquis lobster-potted Rutherford Health (RUTH)  – formerly Neil Woodford favourite Proton Partners – has announced a deal to open new health clinics in partnership with BUPA. Great, whizzo……but there is just one tiny little thing wrong here!

Noting I would keep my watchful eye on Aquis lobster-potted Truspine (TSP) in the wake of a Christmas 2020 update that its FDA-approval paperwork was three months behind more-or-less on deadline day, I see that the company has announced that it has applied for its Cervi-LOK spinal product to be designated as a “Breakthough Device Technology”. Whatever……here we are in November and the FDA 510k application for this device, originally due last Christmas, has still not been filed. But it gets worse……

I cannot help but notice that shares in AIM-listed John Zorbas vehicle URU Metals (URU) have crashed by 19% thus far today, on no news. Having called it a sell at 405p in August, a sell at  320p in September and a sell at 270p earlier this month, the stock is now down to 190p. Of course, it is still a sell but perhaps it is time for an early Ouzo as the shares have now more than halved.

AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) has released a portfolio update this morning. Naturally the BBMs are pleased as punch but I fear that, once again, the company has borrowed the Adam Reynolds (who, for the avoidance of doubt, has nothing to do with Tern) keyboard, for there are no meaningful numbers to be found – and the few included are pitiful.

Oh dear oh dear. AIM-listed jam-tomorrow IoT investment company Tern (TERN) principal investee Device Authority has just posted amended FY20 accounts at Companies House. Given that the original accounts were signed off back in January but not posted until 21 September 2021, that looks like carelessness – as do the missing Notes to the Accounts. And then there is an increased £4.6 million liability, apparently owed to nobody!

When I commented on AIM-listed URU Metals (URU) at the end of August, following the “disposal” of its Zebediela nickel asset to TSX-V listed cash shell (with no cash) Blue Rhino, now Zeb Nickel (TSX-V:ZBNI) the shares were 405p and I said sell as it was an accident waiting to happen. By mid-September they were down to 320p and I still said sell. Now, following after-hours full year results to March, slipped out at no-one-is-watching o’clock on deadline day (never a good sign) – and showing it had net current assets of MINUS $1.5 million – the shares are down again, to 270p – and in my view they are still monstrously overvalued and a sell.

AIM-listed URU Metals (URU) – the firm which prefers to mine its own shareholders rather than anything in the ground, according to Cynical Bear – slipped out its full year results to March last night at 5.35pm on deadline day. Truly, this is no-one-is-watching o’clock, but ShareProphets was watching and the numbers are – again – horrendous.

AIM-listed Rurelec (RUR) has been an untold disaster on AIM. Having ditched the Peter Earl regime, the directors who somehow managed to keep this crock afloat have now left and the outlook is truly grim.

Oh dear, oh dear, oh dear. AIM-listed Advanced Oncotherapy has announced its interims to June: the numbers are predictably dreadful but the killer is surely the indication of a delay to the completion of the company’s first proton therapy LIGHT system.

AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) has a history of not keeping its own investors abreast of what is going on going almost all the way back to when Tern was formed out of the wreckage that was Silvermere Energy back in 2013. An eight year history of deceiving investors?

AIM-listed Igas Energy (IGAS) has reported its interim numbers to June 30 2021 this morning and despite tables covering EBITDA (bullshit earnings), adjusted EBITDA (double bullshit earnings), underlying cash operating costs (more bullshit earnings) and operating cashflow numbers (yet more BS) the bottom line shows that Igas lost another whopping amount and the balance sheet shows that it was technically insolvent. If this isn’t another trainwreck in the making then I’m a banana (to borrow a phrase from Ian Hislop).

AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) has announced a contract for investee Wyld Networks AB (listed on the Nasdaq First Growth market in Stockholm). Woopiedoo! Or is it?

Aquis lobster-pot listed TruSpine (TSP) has announced a placing raising just £650,000 – of which only £500,000 of actual cash was raised (the balance being fee shares, one presumes to the fine Broker involved to cover coke and hookers costs). Quite why anyone would pay 10p for shares which are trading at just 8.75p (up 0.65p) even after the announcement) is beyond me! But the highlight was the update over FDA submission for its Cervi-LOK product.

In my last piece on AIM-listed Haydale (HAYD) at the beginning of this month I discussed a ramparoonie RNS revealing an undeclared related party and a tin-pot organisation casting a very different light on matters as presented by the company. What was the point? Of course – it was a pre-placing ramp and this morning it was time for Ouzo on cornflakes as Haydale revealed a fundraise at just 6p per share. That, against a peak last week of 7.55p.

Last night at 5.20pm AIM-listed Rurelec slipped out its full year results to December 31 2020. Given that its previous team of directors slipped out of the door since period end, the evening of Boris Johnson’s cabinet reshuffle looks like a good time to bury bad news.

On 3 September AIM-listed Angelsey Mining (AYM) released predictably horrid full year results to March 2021. This morning it has graced the market with an RNS entitled Financial Results and way Forward. Confused? I was……until I realised this morning’s missive didn’t include the full results!

AIM-listed Haydale (HAYD) has announced a Memorandum of Understanding with a company called Viritech Limited via and RNS Reach this morning. Of course, and RNS Reach is not a full RNS and should be treated more as marketing material, certainly with no implied financial impact. A trip to Companies House shows us why……

Sub-Standard-Listed Cloudbreak Discovery (CDL), which rushed its way onto the Standard List  only in June as Imperial X (IMPP) before it had even managed to change its name amid a forest of Red Flags, has announced an industrial trough-load of options for directors, PMDRs and other staff. Its nice to be valued, but what about the shareholders?

The last time I commented on AIM-listed Mediazest (MDZ) in May, having previously noted a balance sheet calamity, I called for a statement from the company regarding its chairman, Mr Lance O’Neill and his relationship with Claremont Capital Assets Limited (CCAL) as a related party.Needless to say, we’ve heard nothing from the company about that. This morning, however, we have a trading statement. Given that its next reporting period end is September 30^th, one has to wonder why….until you consider its car-crash of a balance sheet. I suggest this is all leading up to a bucket shop special.

It has been a busy few weeks for AIM-listed John Zorbas vehicle URU Metals (URU). The “sale” of its Zebediela nickel project in South Africa to Toronto Venture Exchange listed (lack-of) cash shell Blue Rhino (RHNO), now renamed ZEB Nickel (ZBNI) has completed, with Zeb having raised some cash along the way. But it seems that the Toronto market is less than impressed.

AIM-listed jam-tomorrow investment company Tern plc (TERN) has announced a portfolio update…..and that it has piled another £630,000 into its portfolio. But that seems to be about the only number offered.

AIM-listed protons beams for cancer outfit Advanced Oncotherapy (AVO) announced a proposed £40 million fundraise yesterday – the largest to date – at 40p per share, a 17% premium to its average closing price over the past month, and a 13% premium to the previous close. I have to hand it to the company, that’s a great effort. But does it make the shares a buy?

AIM-listed Catenae Innovation (CTEA), which is almost revenue-free and surely heading for a Christmas cash-crunch, has announced a “Data Visualisation Oder” from SaxaVord UK Spaceport at a satellite ground station in the Shetland Islands. Good news…..or not, for we are told that revenues created from the order are not significant. So another revenue-free project, then!

I have said before that some people are just in the wrong place at the wrong time. Well, actually, just one. This is with regard to sub-Standard-Listed BSF Enterprise (BSFA) and its new NED as announced this morning.

AIM-listed Catenae Innovation (CTEA) has announced yet another RNS Reach – this time over a deal with Promake Ltd – but it is still, on the basis of its interims to March, almost revenue free and heading for a cash-crunch by Christmas. But never mind that, it’s got a deal with Promake…..which offers yet more Red Flags!

AIM-listed John Zorbas outfit URU Metals (URU) had a good day in the market yesterday as its shares shot up by 8% to 405p on news of developments regarding its “disposal” of the Zebediela nickel project in South Africa to Toronto Venture Exchange listed Blue Rhino (RHNO). Except as far as I can see it is not really a disposal as one might normally understand the word.

I have covered the downs and further downs of AIM-listed Rurelec (RUR) in some detail since the demise of former management led by Peter Earl, and marvelled at the fact that the company – despite everything thrown at it – is still here at all. But this morning’s announcement of a new “Independent” NED makes the stock totally uninvestable. So who is the mystery NED?

AIM-listed alternative energy supplier Yu Group (YU.) has updated the market this morning with a trading statement for the half-year to June. We are told of strong growth in bookings ad revenue with confidence in delivering profitable growth, but whilst cash balances are broadly flat (ie a little down) over the period there is again no discussion of net current assets. So is it just more of the same?

The morning, AIM-listed Catenae Innovation (CTEA) trumpeted a new pilot programme with a charity. Bully for it, but to me this morning’s RNS is extremely bad news and this is why.

What is AIM-listed jam-tomorrow investment company Tern plc (TERN) really worth? At the close of play on Friday the shares were down 11% at 24.5p, valuing the company at £81 million. But its last-stated NAV per share was just 7.3p, which would value the company at a far more modest £24 million. The problem is that Tern’s stated NAV per share has been shown to be (if you’ll pardon the pun) Wyldly optimistic. I believe the last stated NAV should be more like £17.4 million – and that is being generous.

So the truth is out. AIM-listed jam-tomorrow investment company Tern plc (TERN) teased the market with plans to list investee Wyld Networks in Stockholm on the Swedish Nasdaq First North market. The BBMs went (ahem..) wyld with excitement, marking Tern’s shares up as high as 29p against a last-stated NAV per share of just 7.3p as the IPO approached. Tern was going to the moon…….until today.

AIM-listed Catenae Innovation (CTEA) has announced its delayed FY20 results and Interims to March 2021. You can’t say we didn’t warn you: in short, the numbers are calamitous and the shares are an outstanding sell. It is Ouzo on Cornflakes time!

As we all know, intra-day trading statements are usually bad news and today’s update from AIM-listed and holed below the waterline by former management Rurelec (RUR) is no exception.

My five AIM anti-tips for the year continue to defy gravity. I suggested in my last column on this that perhaps it should perhaps be renamed the Market Madness Index. Anyway, for what it is worth, here is how things stand.

Yet more red faces for Andrew Monk and his team at VSA Capital which launched this abomination on the stockmarket and still acts as its adviser. But I guess that coke and hookers don’t pay for themselves and a man’s got to do what a man’s got to do. What a total shambles! Sub-Standard-listed AIQ (AIQ) has announced the result of its strategic review this morning – this as a result of the disastrous reverse takeover of Alchemist Codes to add to the original and equally shambolic IPO on the sub-standard list back in 2018 which saw the stock suspended for most of its first six months on the market.

Fully listed Esken Limited (ESKN), formerly Neil Woodford favourite Stobart Group Ltd (STOB), has announced that – as I suggested back on 31^st May – the sale of Stobart Air and Carlisle Lake District Airport to Ettyl Limited has collapsed. Worse still, support for Stobart Air has been terminated, Stobart Air has terminated its franchise agreement with Aer Lingus, will cease trading and liquidators are to be appointed. The pain for Esken does not end there, but later on it confirmed talks to potentially sell 30% of London Southend airport. But that’s not the whole story……

On Friday morning at 7am fully-listed former Neil Woodford favourite Esken (ESKN) – formerly known as Stobart Group Ltd (STOB) – announced that its proposed sale of Stobart Air to Ettyl Limited was being delayed by change of control consents taking longer than planned. Given that the sale was due to complete by early May 2021 announcing this on the last trading day of May seems a bit ripe. But worse was to follow.

AIM-listed Yu Group (YU.) had its AGM this week. All the resolutions were passed, as one might expect, but the company talked of being profitable in the second half of last year and continued momentum from FY20 as 2021 got off to a good start. But profit – as we all know – is a matter of opinion; cash – where Yu’s dangers lie – is a matter of fact.

AIM-listed and technically insolvent as at Christmas Inspirit Energy Holdings (INSP) has announced yet another discounted placing this morning, raising £500,000 at a price of 0.05p per share, to keep the lights on. That, against a closing price yesterday of 0.06p yesterday means the discount was 16.7%, although for some curious reason the stock has been sliding since May 17 when it was 0.07p. But naturally enough, since this is AIM there is no chance of insider dealing.

Last night, at 6.02pm – no-one-is-watching o’clock – AIM-listed URU Metals (URU) announced it has increased the death spiral facility with an outfit called Boothbay Absolute Return Strategies from $250,000 to $500,000 – and the bargain giveaway conversion terms which were originally due to expire within 90 days of the original loan have again been extended so that Boothbay can convert at just 85p……with the stock trading at 325p!

Things were looking up at AIM-listed Rurelec (RUR) when I last commented here, but yesterday morning came bad news from Argentina. In honour of which our esteemed site editor has added a video to this article which will bring tears to your eyes. But first Rurelec and its news…

AIM-listed Catenae Innovation (CTEA) has waxed lyrical this morning about the acquisition of Hyperneph Software Limited. The acquisition – a 51% partial stake in the outfit – is set to cost Catenae’s grateful shareholders £270,000 in cash and £50,000 in Catenae confetti to be issued at the end of February next year at a 10-day VWAP. The transaction is classed as a Related Party Transaction as one former director of Catenae is on the board of Hyperneph, alongside a former employee and current adviser to Catenae.

It’s Spring cleaning time. And with the markets closed, it’s an ideal time to condemn stuff you don’t want, as charity shops faced with a 17% rise in donations are finding out. And it’s also time to divest yourself of shares which are dragging down your portfolio. It’s been shown time and time again that holding onto duds limit your performance more than finding winners. Nothing is guaranteed in the chaos that is Shareland. But there are a few guidance notes, if not rules, for keeping your portfolio in a tidy and profitable state. Here they are.

Tom Winnifrith has already exposed the cancer threat, discussed HERE in a 2018 scientific study, posed by wearing graphene enhanced face masks with regard to AIM-listed Versarien (VRS). But it seems that Versarien is not the only company in the firing line, for AIM-listed Haydale (HAYD) is also on the hook.

Here is another piece of fake news from Alliance News: “Losses widen at BSF Enterprise but cash position strengthens”. This followed the release by sub-Standard Listed cash-shell BSF Enterprise (BSFA) of Interims to March 2020 – just over three weeks AFTER it released full year numbers to September 2020 (which were released a day late on April 1^st despite having been filed to Companies House on 4^th March. What sort of shambles is this?

Schroder UK Public Private Trust (SUPP) – formerly Neil Woodford’s Patient Capital Trust (WPCT) – slipped out a new but unaudited net asset value statement yesterday at 3.32pm and it was shocking: it wiped another 20% off the previously stated NAV to bring the official figure down to just 35.01p per share. That, against the fantasy 89.07p when the flagship Woodford fund, Woodford Equity Income, was gated on 3 June 2019.

It is a while since I took a look at AIM-listed Igas Energy (IGAS) – the last big round of coverage followed Andrew Austin and his dodgy deal with Equities First, and the subsequent refinancing which we correctly called as the oil price plummeted. Today, the company revealed its accounts for FY20 and there was a striking similarity……

Oh dear, oh dear – I would have thought that the board of AIM-listed John Gunn enterprise (or lack of it) Inspirit Energy Holdings (INSP) would have learnt by its previous errors. But alas, no. For five of the last six years, Inspirit has missed the deadline for filing its Confirmation Statement or Annual Return……and guess what?!

Cash-shell BSF Enterprise (BSFA) of the Sub-Standard List (surely two Red Flags already!) published its FY numbers to 30 September 2020 this morning – April 1^st. Those with a sharp eye might notice they are a day late – which is a bit of a mystery given that they were signed off by the Auditor (PKF Littlejohn) and Geoffrey Baker on behalf of the board a month ago on March 1^st, filed at Companies House on 4^th March and released by Companies House on March 12^th! So much for shareholders finding out what is going on via the RNS system first!

There may be no limit to the stupidity of the lunatic fans of AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) but the market’s early reaction to this morning’s FY20 results – a drop of 18% – suggests that you can’t fool all of the market all of the time. In short, the numbers are a calamity.

AIM-listed Yu Group (YU.) released its Full Year numbers for 2020 this morning which show continued cashburn, a horrible lack of balance sheet support and negative net current assets. As I had suspected, the trumpeted cashpile announced in the FY Trading Update was a mirage, with payables up and receivables down. The shares may have been on a tear recently, but the company is heading for a brick wall.

It was announced this morning that AIM-listed Catenae Innovation (CTEA) is to delay releasing its accounts to 30 September 2020 with the blessing of AIM Regulation, which has given the company until the end of June on the grounds of the Covid pandemic. I will come to this later, but we were also treated to a trading update……which was indeed a treat, if you are a bear.

Technically insolvent AIM POS St James House (SJH) made a song and dance yesterday of its latest bailout rescue finance package – which neither bails it out or rescues it – with Tintra Acquisitions Limited. There is a £250,000 loan convertible into a death spiral at 10p per share (take note shareholders, with the price currently 45p a pop!) but tied to that are two option deals which apparently bring in between them a fraction below £180,000. So how much of that will find its way onto St James’ balance sheet?

The good Professor Conroy and his team at AIM-listed Conroy Gold and Natural Resources (CGNR) must be feeling very pleased with themselves this morning, as the company announced a decent-sized fundraise to bring in £1.87 million in cash (before expenses) and a debt-for-equity swap regarding outstanding director fees and other debts to wipe out £379,000 of monies due. So does this finally cure Conroy’s long-running illness of technical insolvency, as highlighted by the Auditor in November’s FY accounts to May?

Neil Woodford’s shambolic Patient Capital Trust (WPCT) – now Schroder UK Public Private Trust (SUPP) after Woodford’s disgrace – has announced the completion of an asset sale to bring in £52.9 million. In theory this is good news, but since the original sale was announced as being at a 19% discount and the vast majority of the cash is being used to part-pay the bank there really isn’t much to celebrate for shareholders.

When I last looked at fully-listed Hammerson (HMSO) last September, it had just raised money to, in effect, start again. But since then Bonkers Boris has locked the country up for a second and third time and as such there was simply no attraction for me to this property (lack of) income play.

I commented back in January on AIM-listed URU Metals (URU) and its proposed sale of the Zebediela project in South Africa to Canadian-listed cash (-less) shell Blue Rhino Capital. Suffice to say I wasn’t impressed. Yesterday the company called its AGM and on the agenda is this “disposal”.

AIM-listed Mediazest (MDZ) has finally released results for its extended 18-month period to September 2020, and the numbers are a calamity as the Red Ink dribbles from every page. Of course, ShareProphets readers were forewarned, so I hope you have missed out on today’s share price drop of 10.5% thus far.

AIM-listed jam-tomorrow investment company Tern plc (TERN) has offered yet another portfolio update – this time entitled Portfolio News – the fourth such effort so far this year. If at first you don’t succeed (in ramping your shares), try, try and try again! But with nothing of substance to report (Moi? A cynic?) today’s ramparoonie is merely and RNS Reach.

AIM-listed Anglo Asian Mining (AAZ) has walked on its proposal with fellow AIM-listed Conroy Gold and Natural Resources (CGNR) to form a joint venture with Conroy’s gold assets in Ireland. Not such a disaster for Anglo Asian, but there is a question over who pushed who and when. Meanwhile, it seems that Anglo has been replaced by Turkish outfit Demir Export AS.

The long-running saga of AIM-listed Mediazest (MDZ) and its full results continued this morning, with first a promise to release full numbers for the year to September 2021 eventually replaced with a promise to offer up numbers to September 2020 next week. Apart from the comedic cock-up involving Mediazest’s crystal ball, how sure can we be that the promised numbers will indeed be served up in the coming week? Not very, I fancy!

AIM-listed Haydale Graphene (HAYD) has offered up its interims to December 2020 today and whilst the company flags increased sales of functionalised inks graphene and points to falling admin costs and operating losses, these are on an adjusted basis. The unadjusted truth is that sales of £1.277 million were down from £1.347 million the previous year and the company lost £2 million in total comprehensive loss (although this is marked as being for the year – not that there was an cut’n’paste laziness!)

AIM-listed Catenae Innovation (CTEA) offered up more than its fair share of RNS Reaches last year and this morning we have another. Remember, and RNS Reach is classified essentially as marketing material, yet the shares are up by a whopping 45% at 2.75p, having climbed as high as 3.15p!

On February 11^th AIM-listed Mediazest (MDZ) announced that it expects its results for the 18-month period to 30 September 2020 to be announced by the end of the month. Next week is the end of the month – the question is whether its expectations are to be believed, or whether they are in the same mould as Tom Winnifrith’s expectations with regard to Britain’s favourite chanteuse.

AIM-listed Mediazest (MDZ) caught my eye this morning: it is currently top of ADVFN’s gainers leaderboard today with a rise of a very impressive 140%, with a share price of just 0.12p – having been as high as 0.175p. There was news of new business wins due to bring in £350,000 of revenues but as we know, revenues are one thing and cash is quite another. But apart from that, it looks like a forest of Red Flags is upon it: have the Bulletin Board Morons completely lost the plot? TW Note did they ever have it?

I noted the old adage last week of if you don’t succeed, try and try again. Last week AIM-listed jam-tomorrow investment company Tern plc (TERN) offered up its second portfolio update of the year. This morning we were treated to a third: so is it jam-today, then? Or doth the lady protest too much?

If at first you don’t succeed, try and try again. An old rule which it seems that AIM-listed jam-tomorrow investment company Tern plc (TERN) is adhering to. Last month it offered up a Portfolio Update which seemed to me to be meaningless drivel. Now, less than a month later, we have another.

There was bad news this morning from AIM-listed cancer-buster Scancell (SCLP): Cancer Research UK has pulled out of a funding deal to put Scancell’s second SCIB product through Phase I/II trials.

I wondered about the complete non-mention of those clever face masks that AIM-listed Haydale Graphene (HAYD) is supposed to be producing shed-loads of graphene for with regard to the trading statement last week. The more I think about it, the more surprising it is.

AIM-listed Haydale Graphene (HAYD) offered up a statement on Thursday telling of a sales representative agreement and a trading update. The former offered up visions of Tom Winnifrith’s (lack of) wooing Britain’s favourite chanteuse but the latter seems to me have been more a case of the dog that didn’t bark. What was the first elephant in the room?

AIM-listed Catenae Innovation (CTEA) – fresh from its fundraise announced Wednesday which added £1 million to its coffers at 2p per share – has announced a new pilot agreement for its Covid-bandwagon testing platform with an unnamed Fortune 500 American professional services and construction company. But if the BBMs think this is exciting, we are again warned that the deal is not expected to generate substantial revenues. Or, indeed, any revenues at all.

AIM-listed jam-tomorrow investment company Tern plc (TERN) has announced a new injection of capital into investee Wyld Networks offered up by Tern and a third party investor which previously made loans of £400,000 to Wyld. In addition, the two investors have converted loans into equity which cleans up the balance sheet but the big point Tern trumpets is that its previous investment which carried a valuation of £1.2 million is now worth £4.1 million. So it looks a great job for Tern – but I refer readers back to Cynical Bear’s piece on fellow Tern investee Cryptosoft, now called Device Authority, on the merger between Cryptosoft and Device Authority Inc.

Schroder UK Public Private Trust (SUPP) – the former Woodford Patient Capital Trust has today announced the sale of seven assets for a total of £51.9 million. Well done, you might say – until you read that this represents as discount of some 19% to the forex adjusted (as at 25 January) valuations as at 30 September 2020. Not so hot, all of a sudden.

AIM-listed technically insolvent POS Trafalgar Property (TRAF) today announced a director share purchase: CEO Paul Treadaway has bought a million golden tickets. The stock is up on the news, but I fear that this is just a textbook spoof.

Sub-Standard-listed AIQ has had a chequered history since it floated on the London Stock Exchange courtesy of Andrew Monk and VSA Capital. The founding executive directors’ full details had not been correctly disclosed, there was the mother of all shambles as IPO share certificates failed to arrive in a timely manner and at the same time a buying frenzy – perhaps by people who thought there was a relationship to Mama Captain (denied), the stock spent most of its first four months as a listed entity suspended and even a placing to address the IPO shambles was messed up. Meanwhile, the stock was trading (when not suspended) at a ridiculous premium to cash, with no business.

The good news is that we did not have to wait until after-hours on New Year’s Eve for the latest set of Interim Results to September from AIM-listed John Zorbas POS URU Metals (URU). But the numbers are, as predicted, truly awful – it is Red Flags ahoy from this technically insolvent joke company.

At 1.25pm AIM-listed POS Inspirit Energy (INSP) issued a statement relating to fellow AIM-listed Octagonal, where its CEO and Chairman John Gunn, and Finance Director Nilesh Jagatia also reside in the same roles,  whose subsidiary,  Global Investment Strategy is Inspirit’s sole broker – the very same subsidiary which has been charged by the SEC – alongside John Gunn, for aiding and abetting – with violating US broker-dealer registration provisions of the Securities Exchange Act 1934. Given that Jagatia and Gunn make up two thirds of the board of Inspirit, there clearly is a problem here!

As we approach the end of 2020, it is time to take a look back at my Tips of the Year in the ShareProphets Christmas 2019 Tipfest. AIM-listed investment company Tern plc (TERN) was my first tip – as a sell, at 9.25p. So how have I done?

AIM-listed jam-tomorrow (or never) Internet of Things investment company Tern plc (TERN) has seen its shares continue to crater – the shares are now, at 6.7p, well below the last placing price of 7.5p. Meanwhile investee FVRVS Limited (Fundamental VR) has filed its 2019 accounts……and…..oh dear!

Yesterday I took apart the ramptastic announcement from AIM-listed Catenae Innovation (CTEA) regarding its joint venture with BHA Medical, and showed that the JV vehicle was worth just 10p. But the nonsense does not stop there.

AIM-listed Covid-ramp Catenae Innovation (CTEA) has announced that its joint venture with BHA Medical, now renamed Synovate Global Ltd (today the world, tomorrow the universe!), has got two orders for its package involving BHAs Covid test kits and Catenae’s data management platform. Whoopie-do, let’s all pile in –this is going to take over the world. Or not…….there is a catch!

I haven’t written about AIM-listed Vast Resources (VAST) since January, when I said sell  at 0.335p. Well, the stock is now 0.1375p so I guess it is time for an Ouzo – but a director share purchase announcement makes me think it is still a sell.

Corero Network Security (CNS) has made an “Order Intake” update, emphasising “positive progression… reflected in the associated order intake of more than $3 million in the first two months of the final quarter of 2020” – and the shares have currently responded to 9.5p, more than 15% higher. Does this look justified?…

Shares in AIM-listed jam-tomorrow (if ever) investment company have again been dribbling south, closing yesterday at 6.95p. With a load of freshly raised cash and a new investment to boast, surely things are going well for Tern……but alas the market seems to be taking a different view. Of course, Tern has a habit of keeping quiet when there might be something to clear up – such as the recent speculation (unfounded, as it happens) on the BBs about Wyld. And that brings me to its 50%-owned investee InVMA.

Like its AIM-listed little sibling Karelian Diamonds (KDR), fellow AIM-listed Conroy Gold and Natural Resources (CGNR) has had six months to release its FY numbers and waited until no-one-is-watching o’clock on deadline day to admit the grizzly truth. But luckily once again ShareProphets was indeed watching.

AIM-listed Haydale Graphene (HAYD) has announced the great achievement of its Functionalised Graphene Antibacterial Masks project going into production with partner IRPC Public Company. Put up the bunting, get the champagne ordered……or perhaps not, for surely it has missed the boat.

Well blow me down: AIM-listed John Zorbas POS URU Metals (URU) has rattled the tin and got someone to fork up at 230p per share. Apparently that is around a 10% discount, but given the paltry return for the company it says nothing that is good about the company. A few coins for the electricity meter and, er…..that’s about it.

AIM-listed jam-tomorrow investment company Tern plc (TERN) has announced a contract for investee FundamentalVR (FVRVS) but it seems the market in unimpressed and shares in Tern have again fallen below the recent fundraising price.

Previously writing on castings and engineering company Chamberlin (CMH), in February with the shares at 24p I noted financials & Premier Miton concerns. Today a “Trading Update”… and the shares at 9.5p, a further more than 15% lower on the back of it…

Shares in John Zorbas AIM outfit URU Metals (URU) are up today on the news of an advisory board appointment. The company announced the hiring of Mr Justin Cocharne to URU’s advisory board and the shares have motored by 6.4% to 250p but I just have one question: how will URU pay for his services, given that the company is quite clearly technically insolvent?

On Tuesday I wondered whether AIM-listed Tern (TERN) was already conducting a discounted placing as its shares were again falling even in the face of yet more ramptastic news. Now we know that the company was again raising money on the back of fake news in the market which it has failed to comment on as the BBMs were frothing about tiny investee Wyld.

I wonder if AIM-listed jam-tomorrow investment company Tern plc (TERN) is already working on a placing, for this morning’s ramptastic Portfolio Update offered as the market celebrates the vaccine news from Pfizer saw the shares come off 7% to 9.5p before a partial recovery. Are placees already selling, or has the market seen through the promise of yet more jam tomorrow?  But one thing is for certain: Tern needs more cash pronto.

AIM-listed technically insolvent John Zorbas POS URU Metals (URU) announced yesterday that it has for the second time extended the initial 90-day initial notice period on its convertible death-spiral loan by a further 90 days. With the shares at 260p, the initial deal to convert the loan is massively more attractive for the loan shark than the 35% discount that would otherwise apply – so why is URU doing this?

AIM-listed graphene outfit Haydale Graphene Industries (HAYD) was “pleased to announce” its interims to June this morning – I’m not sure why, for a £14 million market capitalisation company to offer up a pre-tax loss of £4.4 million in just six months is surely nothing to be pleased about.

There is that old saying that when good management (although the jury is out on that) meets a bad company it is the reputation of the latter which survives. And that brings me to AIM-listed uber-dog St James’ House (SJH) – formerly Lib Dem grandee Lord Razzall disaster Boxhill Technology (BOX). We’ve had funding not arrive, vacuous trading statements and now this morning the company tells us it cannot get its accounts out on time. So why has AIM Regulation not suspended the shares forthwith?

AIM-listed Advanced Oncotherapy (AVO) has announced a fundraise at 30p to raise £7.7 million (before expenses) – as predicted HERE by yours truly. Time for another glass of Ouzo, methinks.

Evil Knievil always used to say that the best time to kick a man is when he is down. And so I return to AIM-listed jam-tomorrow, next year, never investment company Tern plc (TERN) where I see that the shares are once again down.

I have been warning about AIM-listed jam-tomorrow, next year, never investment company Tern (TERN) for years, but this year made it my sell of the year on the grounds that I thought this would be the year when investors finally gave up on the jam-tomorrow promises. Having hit a high point this year of 15.75p, this morning the stock is down to just 5.5p. But its (claimed) NAV per share is 7p – surely that makes Tern a buy? Er…..

Gary Newman stuck the knife in to AIM-listed Adamas (ADAM) – of the ShareProphets AIM-China Filthy Forty, no less – at the beginning of September when it announced a share buy-back at a higher price than a placing and open offer first announced in July, but which only completed today – and only partially. If that is not bonkers enough, it seems that a large chunk of the placing cash is yet to arrive. We were told yesterday that:

At least we weren’t told anybody was pleased to announce these results on Wednesday morning, but the numbers offered up by AIM-listed Trafalgar Property (TRAF) were once again horrific. And something simply does not ring true.